Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors compared to the general population ...

Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

Oncolytics Biotech Inc. (NASDAQ:ONCY) is included in our list of the stocks under $1 that will explode. Oncolytics Biotech ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

The university says the gift from Austin residents Tench and Simone Coxe is one of the largest in UT Austin's history.

HOUSTON, JANUARY 9, 2026 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm TheranosticsLeading candidate Betabart, a monoclonal antibody targeting B7H3, has received ...